Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Bridged Proteolysis Targeting Chimera (PROTAC) Enables Degradation of Undruggable Targets
Yan Xiong, Yue Zhong, Hyerin Yim, et al.
Journal of the American Chemical Society (2022) Vol. 144, Iss. 49, pp. 22622-22632
Open Access | Times Cited: 69

Showing 1-25 of 69 citing articles:

Recent advances in targeting the “undruggable” proteins: from drug discovery to clinical trials
Xin Xie, Tingting Yu, Xiang Li, et al.
Signal Transduction and Targeted Therapy (2023) Vol. 8, Iss. 1
Open Access | Times Cited: 151
Annual review of PROTAC degraders as anticancer agents in 2022
Xiao Wang, Zhao-Long Qin, Na Li, et al.
European Journal of Medicinal Chemistry (2024) Vol. 267, pp. 116166-116166
Closed Access | Times Cited: 53
Recent Advances in Pro-PROTAC Development to Address On-Target Off-Tumor Toxicity
Chuanjie Chen, Yiwen Yang, Zhe Wang, et al.
Journal of Medicinal Chemistry (2023) Vol. 66, Iss. 13, pp. 8428-8440
Closed Access | Times Cited: 43
New-generation advanced PROTACs as potential therapeutic agents in cancer therapy
Chao Wang, Yujing Zhang, Wujun Chen, et al.
Molecular Cancer (2024) Vol. 23, Iss. 1
Open Access | Times Cited: 27
Discovery of a PROTAC degrader for METTL3-METTL14 complex
Wenhao Du, Yuting Huang, Xiaoai Chen, et al.
Cell chemical biology (2024) Vol. 31, Iss. 1, pp. 177-183.e17
Closed Access | Times Cited: 24
Targeting the undruggables—the power of protein degraders
Chao Zhang, Yongbo Liu, Guangchen Li, et al.
Science Bulletin (2024) Vol. 69, Iss. 11, pp. 1776-1797
Open Access | Times Cited: 18
Ubiquitin-specific proximity labeling for the identification of E3 ligase substrates
Hai‐Tsang Huang, Ryan J. Lumpkin, Ryan W. Tsai, et al.
Nature Chemical Biology (2024) Vol. 20, Iss. 9, pp. 1227-1236
Closed Access | Times Cited: 15
Targeting N-Myc in neuroblastoma with selective Aurora kinase A degraders
Jian Tang, Ramkumar Moorthy, Laura Hirsch, et al.
Cell chemical biology (2025)
Open Access | Times Cited: 2
Antiviral PROTACs: Opportunity borne with challenge
Jinsen Liang, Yihe Wu, Ke Lan, et al.
Cell Insight (2023) Vol. 2, Iss. 3, pp. 100092-100092
Open Access | Times Cited: 32
Targeted protein posttranslational modifications by chemically induced proximity for cancer therapy
Yunhua Peng, Jing Liu, Hiroyuki Inuzuka, et al.
Journal of Biological Chemistry (2023) Vol. 299, Iss. 4, pp. 104572-104572
Open Access | Times Cited: 31
Acetylation Targeting Chimera Enables Acetylation of the Tumor Suppressor p53
Md Kabir, Ning Sun, Xiao Hu, et al.
Journal of the American Chemical Society (2023) Vol. 145, Iss. 27, pp. 14932-14944
Closed Access | Times Cited: 26
PROTACs: A novel strategy for cancer drug discovery and development
Xin Han, Yi Sun
MedComm (2023) Vol. 4, Iss. 3
Open Access | Times Cited: 24
Restraining the power of Proteolysis Targeting Chimeras in the cage: A necessary and important refinement for therapeutic safety
Renshuai Zhang, Songbo Xie, Jie Ran, et al.
Journal of Cellular Physiology (2024) Vol. 239, Iss. 5
Closed Access | Times Cited: 10
Antitumor Effect of Anti‐c‐Myc Aptamer‐Based PROTAC for Degradation of the c‐Myc Protein
Yuchun Wang, Gang Yang, Xinyu Zhang, et al.
Advanced Science (2024) Vol. 11, Iss. 26
Closed Access | Times Cited: 9
Development of PROTAC degrader probe of CDK4/6 based on DCAF16
Chunlan Pu, Yuanyuan Liu, Rui Deng, et al.
Bioorganic Chemistry (2023) Vol. 138, pp. 106637-106637
Closed Access | Times Cited: 18
Dual‐Programmable Semiconducting Polymer NanoPROTACs for Deep‐Tissue Sonodynamic‐Ferroptosis Activatable Immunotherapy
Fengshuo Wang, Guoqiang Dong, Mengbin Ding, et al.
Small (2023) Vol. 20, Iss. 8
Closed Access | Times Cited: 17
Discovery of LL-K8-22: A Selective, Durable, and Small-Molecule Degrader of the CDK8-Cyclin C Complex
Mingyu Wang, Rongkun Lin, Jiacheng Li, et al.
Journal of Medicinal Chemistry (2023) Vol. 66, Iss. 7, pp. 4932-4951
Closed Access | Times Cited: 16
Targeting autophagy drug discovery: Targets, indications and development trends
Mengjia Jiang, Wayne Wu, Zijie Xiong, et al.
European Journal of Medicinal Chemistry (2024) Vol. 267, pp. 116117-116117
Closed Access | Times Cited: 7
Discovery of the First-in-Class G9a/GLP PROTAC Degrader
Julia Velez, Yulin Han, Hyerin Yim, et al.
Journal of Medicinal Chemistry (2024) Vol. 67, Iss. 8, pp. 6397-6409
Open Access | Times Cited: 6
Recent Progress in DNA Damage Response-Targeting PROTAC Degraders
Binbin Cheng, Xiaoting Fei, Zongbao Ding, et al.
Journal of Medicinal Chemistry (2024) Vol. 67, Iss. 9, pp. 6906-6921
Closed Access | Times Cited: 6
Mitochondrial Protease Targeting Chimeras for Mitochondrial Matrix Protein Degradation
Dachi Wang, Wenxi Wang, Le Fang, et al.
Journal of the American Chemical Society (2023) Vol. 145, Iss. 23, pp. 12861-12869
Closed Access | Times Cited: 13
PROTACs Targeting MLKL Protect Cells from Necroptosis
Oliver H. Rathje, Lara Perryman, Richard J. Payne, et al.
Journal of Medicinal Chemistry (2023) Vol. 66, Iss. 16, pp. 11216-11236
Closed Access | Times Cited: 13
Discovery and Characterization of a Novel Cereblon-Recruiting PRC1 Bridged PROTAC Degrader
Md Kabir, Lihuai Qin, Kaixiu Luo, et al.
Journal of Medicinal Chemistry (2024) Vol. 67, Iss. 8, pp. 6880-6892
Closed Access | Times Cited: 5
Amphiphilic Affibody-PROTAC conjugate Self-Assembled nanoagents for targeted cancer therapy
Wenhui Gao, Xuelin Xia, Xiaoyuan Yang, et al.
Chemical Engineering Journal (2024) Vol. 495, pp. 153437-153437
Closed Access | Times Cited: 5
Targeted degradation of LRG1 to attenuate renal fibrosis
Linyao Fan, Yingqiu Qi, Xi Yang, et al.
Asian Journal of Pharmaceutical Sciences (2024) Vol. 19, Iss. 4, pp. 100941-100941
Open Access | Times Cited: 5
Page 1 - Next Page

Scroll to top